Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In some cases, it can cause other problems, such as: Severe GERD (gastroesophageal reflux disease)
For most patients starting GLP-1 treatment for weight management, semaglutide (either Wegovy or compounded) is a common first choice because it has the longest track record, the most clinical data, and the widest availability
Clinical Trial Data The landmark STEP-1 trial studied Wegovy (semaglutide 2.4 mg) in 1,961 adults over 68 weeks
The following serious adverse reactions are described in greater detail elsewhere in labeling: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
Compression stockings can help maintain venous return during extended periods of immobility
Your provider can assess potential interactions, adjust dosing appropriately, and monitor for any adverse effects
